In addition to the marginal association between increased CD14 with higher risk of AD, increased CD5L was also marginally associated with higher risk of incident AD within 10 years of follow-up (HR = 1.22, 95% CI = (0.88, 1.36), p = 0.03, FDR = 0.15). Here, CD5L is linked to Alzheimer disease.